Products for Research Use Only

Recombinant Human CDKN2A

CAT: 0013-GTR18894034-02Size: 100 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR18894034-02Size:100 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Recombinant Human P16-INK4A
Product Name Alternative
Alternative reading frame, ARF, CDK4 inhibitor p16 INK4, CDK4I, CDKN2, cell cycle negative regulator beta, CMM2, cyclin dependent kinase 4 inhibitor A, cyclin dependent kinase inhibitor 2A, cyclin dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLM, MTS 1, MTS1, multiple tumor suppressor 1, P14, P14ARF, P16, P16 INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16
UniProt
P42771
Expression Region
1-156
Reactivity
Human
Tag
N-terminal His Tag
Source
E.Coli
Field of Research
Cancer, Epigenetics
Purity
Greater than 95% by SDS-PAGE gel analyses
Molecular Weight
18.4 KDa
Storage Conditions
-20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution
Notes
For research use only.
Applications Notes
Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/ml in sterile distilled water by gentle pipetting 2-3 times, don’t vortex
Tested Applications
ELISA, WB
Preservative
Lyophilized from a 0.2 μm filtered solution in PBS with 5% trehalose, pH 7.4

UniProtKB · P42771

Cyclin-dependent kinase inhibitor 2A

CDN2A_HUMAN · Homo sapiens

View on UniProt ↗
Primary accession
P42771
Review status
UniProtKB reviewed (Swiss-Prot)
Gene
CDKN2A
Protein existence
1: Evidence at protein level
Organism
Homo sapiens (Human)
Taxonomy ID
9606
Alternative names
—
EC number
—
Processing
—
Secondary accessions
A5X2G7, D3DRK1, G3XAG3, O95440, Q15191, Q5VVJ5, Q96B52, Q9NP05
Protein keywords

Technical term

3D-structureProteomics identificationReference proteome

PTM

AcetylationPhosphoprotein

Coding sequence diversity

Alternative splicing

Domain

ANK repeatRepeat

Biological process

Cell cycle

Cellular component

CytoplasmNucleus

Disease

Disease variantLi-Fraumeni syndromeTumor suppressor